Lipari N, Galfano A, Venkatesh S, Grezenko H, Sandoval I, Manfredsson F
Front Neural Circuits. 2024; 18:1463941.
PMID: 39634948
PMC: 11615880.
DOI: 10.3389/fncir.2024.1463941.
Beehler B, Tosin M, Stebbins G, Goetz C
Mov Disord Clin Pract. 2024; 12(2):210-214.
PMID: 39382196
PMC: 11802653.
DOI: 10.1002/mdc3.14225.
Pisani S, Gosse L, Aarsland D, Chaudhuri K, Ballard C, Ffytche D
BMJ Ment Health. 2024; 27(1):1-10.
PMID: 39043465
PMC: 11268075.
DOI: 10.1136/bmjment-2024-301062.
dAngremont E, van der Zee S, Slingerland S, Slomp A, de Vries E, van Laar T
Brain. 2024; 147(10):3370-3378.
PMID: 38864492
PMC: 11449127.
DOI: 10.1093/brain/awae186.
Juceviciute N, Balnyte R, Laucius O
Medicina (Kaunas). 2024; 60(4).
PMID: 38674252
PMC: 11051838.
DOI: 10.3390/medicina60040606.
Therapeutic singing-induced swallowing exercise for dysphagia in advanced-stage Parkinson's disease.
Yeo M, Hwang J, Lee H, Kim S, Cho S
Front Neurol. 2024; 15:1323703.
PMID: 38628693
PMC: 11018993.
DOI: 10.3389/fneur.2024.1323703.
Risk of long-term care admissions among Medicare beneficiaries treated with pimavanserin or quetiapine for Parkinson's disease psychosis in USA: a retrospective administrative claims database analysis.
Rajagopalan K, Rashid N, Doshi D
J Comp Eff Res. 2023; 13(1):e230114.
PMID: 38099518
PMC: 10842290.
DOI: 10.57264/cer-2023-0114.
Risk of hospitalization in synucleinopathies and impact of psychosis.
Piat C, Mullan A, Stang C, Hajeb M, Camerucci E, Turcano P
Front Aging Neurosci. 2023; 15:1274821.
PMID: 37810618
PMC: 10557428.
DOI: 10.3389/fnagi.2023.1274821.
Pimavanserin treatment increases plasma brain-derived neurotrophic factor levels in rats.
Tripathi A, Nasrallah H, Pillai A
Front Neurosci. 2023; 17:1237726.
PMID: 37712092
PMC: 10499044.
DOI: 10.3389/fnins.2023.1237726.
Learning to PERSEVERE: A pilot study of peer mentor support and caregiver education in Lewy body dementia.
Fleisher J, Suresh M, Levin M, Hess S, Akram F, Dodson D
Parkinsonism Relat Disord. 2023; 113:105492.
PMID: 37385161
PMC: 10527787.
DOI: 10.1016/j.parkreldis.2023.105492.
Combined multidisciplinary in/outpatient rehabilitation delays definite nursing home admission in advanced Parkinson's disease patients.
Steendam-Oldekamp E, Weerkamp N, Vonk J, Bloem B, van Laar T
Front Neurol. 2023; 14:1128891.
PMID: 37122300
PMC: 10133548.
DOI: 10.3389/fneur.2023.1128891.
Artificial intelligence-based clustering and characterization of Parkinson's disease trajectories.
Birkenbihl C, Ahmad A, Massat N, Raschka T, Avbersek A, Downey P
Sci Rep. 2023; 13(1):2897.
PMID: 36801900
PMC: 9938890.
DOI: 10.1038/s41598-023-30038-8.
Tinetti balance performance is associated with mortality in older adults with late-onset Parkinson's disease: a longitudinal study.
Laurent L, Koskas P, Estrada J, Sebbagh M, Lacaille S, Raynaud-Simon A
BMC Geriatr. 2023; 23(1):54.
PMID: 36717787
PMC: 9887890.
DOI: 10.1186/s12877-023-03776-7.
Changes in both top-down and bottom-up effective connectivity drive visual hallucinations in Parkinson's disease.
Thomas G, Zeidman P, Sultana T, Zarkali A, Razi A, Weil R
Brain Commun. 2023; 5(1):fcac329.
PMID: 36601626
PMC: 9798302.
DOI: 10.1093/braincomms/fcac329.
IN-HOME-PDCaregivers: The effects of a combined home visit and peer mentoring intervention for caregivers of homebound individuals with advanced Parkinson's disease.
Fleisher J, Suresh M, Klostermann E, Lee J, Hess S, Myrick E
Parkinsonism Relat Disord. 2022; 106:105222.
PMID: 36446676
PMC: 9825655.
DOI: 10.1016/j.parkreldis.2022.11.014.
Supporting Relatives Prior to Caregiver Burden-Preventive E-Mental Health Short Intervention for Family Members of Individuals with Parkinsonism in an Early Phase of the Disease: Protocol for a Feasibility Study.
Muente C, Folkerts A, Kalbe E, Thieken F, Assmann L, Widritzki M
Brain Sci. 2022; 12(4).
PMID: 35447974
PMC: 9024797.
DOI: 10.3390/brainsci12040442.
Impact of Isolation During the COVID-19 Pandemic on the Patient Burden of Parkinson's Disease: A PMD Alliance Survey.
Hermanowicz N, Ospina M, Torres-Yaghi Y, Gould S, Papesh K, Rivera J
Neuropsychiatr Dis Treat. 2022; 18:633-643.
PMID: 35355505
PMC: 8958201.
DOI: 10.2147/NDT.S351691.
Incidence, Prevalence, and Mortality of Psychosis Associated with Parkinson's Disease (1991-2010).
Stang C, Mullan A, Camerucci E, Hajeb M, Turcano P, Martin P
J Parkinsons Dis. 2022; 12(4):1319-1327.
PMID: 35213389
PMC: 9336204.
DOI: 10.3233/JPD-213035.
Parkinson's Disease With Visual Hallucinations Is Associated With Epileptiform Activity on EEG.
Fry A, Singh D, Manganas L, Gordon M, Christodoulou C, Leung H
Front Neurol. 2022; 12:788632.
PMID: 35087470
PMC: 8787040.
DOI: 10.3389/fneur.2021.788632.
Longitudinal thalamic white and grey matter changes associated with visual hallucinations in Parkinson's disease.
Zarkali A, McColgan P, Leyland L, Lees A, Weil R
J Neurol Neurosurg Psychiatry. 2021; 93(2):169-179.
PMID: 34583941
PMC: 8785065.
DOI: 10.1136/jnnp-2021-326630.